The Global Fund Grant
The 89th meeting of India's Country Coordinating Mechanism (CCM) discussed The Global Fund grant for TB, HIV/AIDS, and Malaria, highlighting the partnership since 2002, fund disbursement, and key programmatic and financial monitoring mechanisms. The allocation and proportion of domestic budgets, as well as the selection process for non-government principal recipients, were also addressed.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
The Global Fund Grant for TB, HIV/AIDS & Malaria 89thMeeting of India CCM under chairpersonship of Shri Sudhansh Pant, Secretary HFW 14thAugust 2023
An Introduction to the Global Fund The Global Fund has a sustained partnership with India since 2002, with $2.38 billion grant disbursed so far for HIV, TB and Malaria disease programmes. India has contributed $93.5 m to Global Fund since 2002 Department of Economics Affairs, Ministry of Finance, Government of India (GOI) is the Government Principal Recipient with CTD, NACO and NCVBDC being lead implementers. All grant agreements are signed between Global Fund and Principal Recipients.
Fund Flow Mechanism Global Fund Government PR Principal Recipients Non (Department of Economic Affairs) Government PR (NGPR) Lead CTD NACO NCVBDC Implementers (Tuberculosis) (HIV/ AIDS) (Malaria) Payment for Results modality Input based modality Input based modality
Programmatic & Financial Monitoring Non Government PR Government PR Periodic reviews at the level of National Programme/ State Periodic External Financial Audits CAG audits and State level audits programmatic and financial reviews Internal Audit The Oversight Committee of India CCM conducts visits and reviews to oversee the grant implementation during the course of the grant and provide recommendations. Local Fund Agent/ Office of Inspector General of the Global Fund verifies the financial and programmatic achievement. States are visited to verify documents at the facility level.
GF approved allocation & proportion of Domestic budgets (2021-24) Particulars TB HIV/AIDS Malaria Total GF total approved allocation ( INR in Crore) 1,462.51 738.68 389.56 2590.75 (FY 21-22) - 3409.94 (FY 22-23) - 2656.83 (FY 23-24) - 3057.42 Total 9,124.19 (FY 21-22) - 2900.00 (FY 22-23) - 2625.72 (FY 23-24) - 2916.97 Total 8,442.69 (FY 21-22) - 1377.60 (FY 22-23) - 638.17 (FY 23-24) - 581.00 Total - 2596.78 Total domestic budget (BE) (INR in crore) 20,163 16% 8.7% 15% 12.8% % contribution of GF to total Budget
Global Fund Non - Government Principal Recipient selection process
GF guidelines on Dual Track Financing Dual Track Financing is an approach where funding is provided to both Government Programme Divisions and Civil Society Organisation for implementation of activities. Dual Track financing is applicable to specific disease programme separately. This is strongly recommended by Global Fund to all countries; if Non-Government implementing partner is not required by any country, justification for same need to be provided. This is to encourage the engagement of Civil Societies and Community Based Organizations in the implementation process as a stakeholder. Since the funding to the Non-Government Principal Recipient is extra Budgetary, this provides additional support to the Disease programs.
Process of Selection of Non-Government Principal Recipient EOI published on websites of India CCM & programme divisions Applications are invited from interested organizations The EOI requests for information on organizational capacity including financial capacity to mitigate any risks, the organizations experience and a technical sample proposal based on certain thematic areas Publication of EOI A committee consists of members from all stakeholders The committee examines the EOIs received and suggest its recommendations based of pre defined eligibility criteria on selection of Non Government PRs Screening Committee Link for EOI : https://india-ccm.in/eoi-for-selection- of-non-government-principal- recipients-under-gfatm-for-the-grant- period-2024-2027/ The recommendations of the committee are put forth to the CCM for inputs and concurrence. CCMs endorse the Non Govt. PRs. India CCM
Process of selection of Priority thematic areas Community and Stakeholder consultations Multiple consultations are held by the programme divisions and the India CCM Secretariat to gather inputs from all stakeholders The committee consists of members from the national programme, multilateral and bilateral partners, civil society and community members. Scope is to firm up the priority areas of implementation & develop the funding request consultatively and inclusively Disease Specific Technical Committee meetings India Country Coordinating Mechanism Final endorsement of funding request including PR wise allocations
Funding Request endorsement The funding request developed in accordance with the inputs and under guidance of Disease specific Technical Committees by NACO, CTD and NCVBDC is approved by respective programme leadership and then put up to ICCM for its endorsement The funding request including PR wise budget allocation and activities was endorsed by India Country Coordinating Mechanism in its 88th meeting held on 25th May 2023 under chairpersonship of Secretary, Health / Chair, I-CCM Since the Ministry asked for reworking on NGPR selection and priority areas, the process of EoI was repeated and revised concept notes are placed before ICCM in 89th meeting convened on 14th August 2023
Agenda1--Action taken on agenda points and endorsement of Minutes of Meeting of 88th meeting of India CCM dated 25th May 2023
Actionables from 88th meeting of India CCM Agenda Item No. 2: Debrief session on Evolution Threshold results by Global Fund CCM Hub team. India CCM endorsed the results of the CCM Evolution Threshold with certain qualifications. Two areas for strengthening of ICCM were identified as Oversight and Engagement by ICCM taskforce set up for the purpose Agenda Item No. 3: Update on HIV,TB and Malaria Funding Request Proposal for Global Fund grant period 2024-27 and endorsement by India CCM for submission to the Global Fund by 29th May 2023. Funding request proposal was endorsed by India CCM but was not submitted. The process was repeated, and Screening Committee shortlisted organizations for being Non Govt PRs for Global Fund grant cycle 2024- 27 No pending actions
Endorsement of Minutes of 88th meeting of India CCM Since no inputs were received from any CCM Members/Alternates even after circulation, the minutes of 88th India CCM meeting dated 25th May 2023 may be considered Endorsed .
Agenda 2: Update on Non-Government Principal Recipient Selection process, priority areas and recommendations by Screening Committee for shortlisting of NGPRs for upcoming Global Fund grant for grant period (2024-2027).
Disease wise summary of Allocation for 2024-27 Eligible disease Allocation (US$) Allocation Utilization Period component HIV 155,000,000 1 April 2024 to 31 March 2027 Tuberculosis 280,000,000 1 April 2024 to 31 March 2027 Malaria 65,000,000 1 April 2024 to 31 March 2027 Total 500,000,000
Submission Windows Submission Windows The Global Fund CT in their communication dated 21st December 2022 have sent the formal allocation letter to India for the Global Fund s 2023-2025 allocation period (2024- 2027 implementation period). Three windows for submission of Country Funding proposal will be: Window Submission date Technical Review Panel review 1 20 March 2023 April - May 2023 2 29 May 2023 July 2023 3 21 August 2023 September-October 2023
Screening Committee Composition for Revised process Name Designation/Organisation S.No Dr. Atul Goel DGHS as Chair of Committee 1 Dr. R P Joshi DDG (TB) 2 Dr. U B Das DDG (NACO) 3 Dr. Tanu Jain Director (NVBDCP) 4 Ms. Nandini Kapoor Senior Technical Adviser, UNAIDS/ Chair OC I-CCM 5 Dr. Ranjani Ramchandran NPO (Labs), WHO/ Alt Member I-CCM 6 Dr. Shubnum Singh Director (MHC), CII/ Member I-CCM 7 Prof. Ramila Bisht Professor JNU/ Member I-CCM 8 Ms. T Mercy Annapoorni HIV CSO Constituency/ Member I-CCM 9 Mr. Sudeshwar Singh TB PLWD Constituency/Member I-CCM 10 Dr. Ravi Kumar KP Malaria Constituency, Alt Member I-CCM 11
Revised Non-Government PR Selection Process The same Screening Committee with identical ToR constituted for the EoI process in February March 2023 was set up with the approval of Secretary (HFW)/Chair, India CCM under the Chairpersonship of DGHS to shortlist received applications for Non- Government PRs selection under the upcoming Global Fund Grant (2024-2027) in the revised process. The experience clause in the EoI document was relaxed to Should have demonstrated experience of working in health sector preferably in HIV/TB/Malaria for at least 3 years instead of 5 years of HIV/TB Malaria experience including health systems Expression of Interest (EoI) from interested Non-Government institutions was floated on the websites of India CCM, MoHFW and Programme Divisions (NACO, CTD and NCVBDC) from 28th July 2023 to 13th August 2023.
Revised Non-Government PR Selection Process (contd) An open and transparent process was followed with the bid opening meeting on 14th July 2023 and Screening Committee meetings held thereafter on 20th July 2023, 28th July 2023 and 9th August 2023. India CCM Secretariat received a total of 49 applications (49 proposals from 25 organizations) till closing date i.e13th July (23.59 PM) All the applications were screened as per 5 eligibility criteria as specified in the EoI. Programme division representatives along with the community members and representatives of bilaterals and other sectors scrutinized the proposals and gave objective scoring as laid down in the EoI document and went through the submitted proposals and documents in detail
Revised Non-Government PR Selection Process (Contd..) Scoring parameters given below as per the EoI: 1. Organizational capacity 25 marks 2. Experience and Past projects in HIV/TB/ Malaria including Health Systems 25 marks 3. Proposed Technical Proposal 50 marks It was decided that 60 marks be considered as the cut-off score for selection as prospective PRs as per previous exercise to maintain uniformity.
The Screening Committee recommended the following 14 organizations as prospective NGPRs for GF grant period 2024-27 as detailed below: Sl No Name of Organization Type of Organization 1 Karnataka Health Promotion Trust (KHPT) Trust India HIV AIDS Alliance (IHAA) 2 Company The International Union Against Tuberculosis and Lung Disease (The Union) Others-India Branch office with RBI permission 3 4 Tata Institute of Social Sciences (TISS) Others- Academic Institute YR Gaitonde Centre for AIDS Research and Education (YRGCARE) 5 Trust Transport Corporation of India Foundation (TCIF) Trust 6 7 India Health Action Trust (IHAT) NGO
The Screening Committee recommended the following 14 organizations as prospective NGPRs for GF grant period 2024-27 as detailed below: Sl No Name of Organization FIND Type of Organization Company 8 Trust Solidarity and Action Against The HIV Infection in India (SAATHII) 9 Trust Hindustan Latex Family Planning Promotion Trust (HLFPPT) 10 PLAN India Society 11 William J Clinton Foundation WJCF Company 12 Project Concern India (PCI) Society 13 DOCTORS FOR YOU Society 14
Non Govt PRs for Global Fund grant period 2024-2027-- TB Sl No Name of Organization Type of Organization 1 Karnataka Health Promotion Trust (KHPT) Trust Others-Branch office with RBI The UNION (TB) 2 permission Tata Institute of Social Sciences (TISS) Others- Academic Institute 3 FIND-TB Company 4 Trust SAATHII-TB 5 Trust HLFPPT-TB 6 PLAN India-TB 1-SCM Society 7 PLAN India-TB 2-PMTBMBA 8 William J Clinton Foundation WJCF- TB Society 9 DOCTORS FOR YOU Society 10
Non Govt PRs for Global Fund grant period 2024-2027-- HIV Sl No Name of Organization Type of Organization India HIV AIDS Alliance (IHAA) (HIV) 1 Company The UNION (HIV) Others-Branch office with RBI permission 2 YR Gaitonde Centre for AIDS Research and Education (YRGCARE) Trust 3 Transport Corporation of India Foundation (TCIF)-HIV-1 Trust 4 Trust Transport Corporation of India Foundation (TCIF)-HIV-2 5 India Health Action Trust (IHAT)-HIV 6 NGO FIND-HIV Company 7 Solidarity and Action Against The HIV Infection- SAATHII 8 Trust HLFPPT-HIV Samarthya Trust 9 HLFPPT-TSU Trust 10 PLAN India-HIV 1-COMPOSITE Society 11 PLAN India-HIV 2-COMMODITIES NACP Society 12 William J Clinton Foundation WJCF- HIV Company 13
Non Govt PRs for Global Fund grant period 2024-2027-- Malaria Sl No Name of Organization Type of Organization Transport Corporation of India 1 Trust Foundation (TCIF)- Malaria PLAN India-Malaria Society 2 William J Clinton Foundation WJCF- Company 3 MALARIA PCI Malaria Society 4
Summary of recommendations Screening Committee Out of the 39 proposals submitted by 17 eligible organizations, 27 proposals of 14 organizations were found to have average scores above the cut off of 60 marks as shown in previous slides. Performance and Impact assessment of NGPRs may be incorporated by the Programme Divisions to be included as a mid term exercise in the upcoming grant period, since such a mechanism does not exist currently. It should be flagged to the ICCM that due consideration be given by selected PRs to engage indigenous organizations which had applied for PR-ship but could not qualify the financial or technical criteria but have good working experience at the field level as SRs and SSRs.
Summary of recommendations Screening Committee It was strongly recommended to build more enabling conditions for more indigenous organizations to become SRs and SSRs of selected PRs which will also enable the capacity building of such organizations. In addition, more involvement of communities and community based organizations especially in the field of TB for SRs and SSRs should be undertaken so that it will aid in their capacity building. In light of fewer NG PR for Malaria, the selected PRs of HIV and TB may be encouraged to expand their scope of work and also submit proposals for Malaria as per programme needs for future. It may be duly deliberated and discussed with the Global Fund to bring down the financial criteria for selection of non Government Principal Recipients from 10 mUSD to 5 mUSD for the next round of grant cycle.
Disease Specific Technical Committees HIV Malaria TB Dr. Tanu Jain, Director, NCVBDC--as Chair of the committee Ms. Nidhi Kesarwani, Director NACO as Chair of the Committee Dr. R. P. Joshi, DDG (TB), CTD-- as Chair of the Committee Dr. U.B. Das DDG NACO Dr. A.K. Puri DDG NACO Dr. Shobini Rajan, DDG, NACO Dr. Chinmoyee Das ADG, NACO Mr. Rajendra Kumar, Deputy Secretary (Admin) Dr. Sheela Godbole Director, NARI Mr. David Bridger Country Director, UNAIDS Dr. Po Lin Chan Regional Technical Lead, WHO Ms. Anandi Yuvaraj HIV PLWD Constituency, Member, I-CCM Dr. Rinku Sharma--Joint Director,NCVBDC Dr. Raghuram Rao ADG(TB), CTD--as Member Secretary Dr. Vinod Choudhary-- Medical Officer, NCVBDC Fr. Paul Moonjely -- Director, CARITAS, Ex I-CCM member Dr. Raghavan Gopa Kumar-- KP TB Constituency, Member, I-CCM Dr. Matin Ahmad Khan-- CSO TB, Alt Member, I-CCM Dr. Rupak Singla-- TB expert Mr. Diptendu Bhattacharya, SATB, Alt Member I-CCM Dr. P. K. Srivastava-- Former Joint Director, NVBDCP, VBD expert OC Member- I-CCM Mr. Bhakta Bihari Mishra-- Malaria CSO/ Member I-CCM Mr. Samir Kumar Sahu-- Malaria PLWD/ Member I-CCM Dr. Ravi Kumar Malaria -- Malaria PLWD/ Member I-CCM Dr. Roop Kumari (NPO, Malaria) Dr. Reuben Swamickan, Division Chief (TB & Infectious Diseases), USAID Dr. Ranjani Ramachandran, NPO-WHO, Alt Member, I-CCM Ms. Bharati De HIV-KP Member, I-CCM Mr. Abou Mere IDU representative Dr. Bhawani Singh, DD, NACO, Member Secretary Ms. Sapna Surendran, Consultant, World Bank Dr. Manju Rahi (Director in Charge NIMR)
Agenda3--Reconstitution of Oversight Committee 2024-2026
Role and Term of Oversight Committee Role of Oversight Committee is to review and monitor the interventions particularly by the NGPRs during a grant cycle against approved plans, activities and targets. This is done through review meetings, desk review of progress reports and Oversight visits to project sites and stakeholders engagement. The defined term for Oversight Committee is 2 years. The tenure for the current OC was from 1st January 2020 till 31st December 2023 (after an exceptional extension was granted for 1 year 2022-23 due to covid situation in the country) Consequently, a new OC needs to be reconstituted from 1st January 2024
Members of Oversight Committee 2020-23 S.No . NAME DESIGNATION/ CONSTITUENCY Ms.Nandini Kapoor Dhingra Dr.Raghavan Gopa Kumar Founder Member, Tech.Adv. Committee Member (Interim Gov.Board), Touched by TB, Vice Chair OC Dr.Naresh Goel Public Health Expert/ Former DDG (NACO) Sr.Tech.Advisor, UNAIDS, Chair Oversight Committee 1 2 3 Dr.Sangeeta Kaul Public Health Expert/ Former Team Leader (A),HIV/AIDS Div.,Health Office USAID HIV Division Head, USAID 4 Dr.Deepika Joshi Dr. Amar N Shah Srivastava 5 Sr. Health Office, USAID/India Former Joint Director & Head-Vector Control & Entomology, NCVBDC TB Advisor (Strategy and Innovation) 6 Dr.P.K.Srivastava 7 Ms.T.Mercy Annapoorni Executive Director, Blossom Trust 8
Members of Oversight Committee 2020-23 contd.. S.No . NAME DESIGNATION/ CONSTITUENCY Mr.Pratik Raval Assistant Director, GIPA, Gujarat SACS 9 Mr.Sudeshwar Kr.Singh Secy.TB Mukt Vahini 10 Ms.Ramila Bisht Prof, Centre for Social Med, & Community Health, JNU, ND 11 Mr.Moses Pachuau Zofaka President, IDUF 12 Three vacancies 13,1 4,15
OC nominations for vacant seats from India CCM There are three vacancies in OC currently out of a total 15 OC members, and it was agreed in the 88th meeting of India CCM to seek willingness from current ICCM community and civil society representatives As directed, India CCM Secretariat sent mails for the 3 vacant positions from interested CCM members/alternates indicating their willingness for inclusion in the OC. Dr. Ravi Kumar, Ms. Celina Menezes, Mr.Vijay Nair, Mr. Samir Sahu, Mr. Bhakta Bihari and Mr. Shridhar Pandey indicated their willingness over mail. One representative from each disease constituency may be included to be a part of the OC as decided in present meeting.
Oversight Committee Composition requirements The Oversight Committee shall be appointed by the ICCM, and shall consist of a Chair, a Vice Chair, and at least five additional members representing various constituencies. Members of the OC shall not be representatives of PRs or SRs Non CCM Members may be included as part of the committee. OC Members are required to declare conflict of interest by submitting a prescribed declaration form. As per ICCM Oversight Plan, at least 1/3rd of the members must be new. In present instance, Dr. Sangeeta Kaul and Ms. Mercy Annapoorni have completed two terms and may not continue as an OC Member.
Steps for nomination to Oversight Committee Step-1 Calling for nominations from interested and eligible Current OC members, CCM and Non-CCM Members through an EoI. The detailed CV and the Skill Matrix format to be duly filled up and shared with India CCM Secretariat on its email id iccmsect-mohfw@gov.in by due date (within 3 week of EoI issuance) Step-2 Shortlisting of Eligible applications over next two weeks Step-3 Formation of a screening committee for finalization of OC committee members from the shortlisted applications over next two weeks Step-4 Formation of the Oversight Committee with due approvals after circulation of draft OC composition with full ICCM for timebound inputs and thereafter appraisal in next ICCM meeting
THANKS! 44
